Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors
NCT05207787
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
HS-10365
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.